Analysen von Charles Pitman-King

07.01.26 Merck Equal Weight Barclays Capital
07.01.26 Sartorius Stedim Biotech Overweight Barclays Capital
07.01.26 Sartorius vz. Overweight Barclays Capital
07.01.26 Bayer Overweight Barclays Capital
02.12.25 Bayer Equal Weight Barclays Capital
24.11.25 Bayer Equal Weight Barclays Capital
01.10.25 Sartorius Stedim Biotech Overweight Barclays Capital
01.10.25 Sartorius vz. Overweight Barclays Capital
23.07.25 Sartorius vz. Overweight Barclays Capital
18.06.25 Sartorius vz. Overweight Barclays Capital
12.05.25 Merck Overweight Barclays Capital
26.02.25 Sartorius vz. Overweight Barclays Capital